In the murine model of colitis, GSDMD is activated during intestinal inflammation and is confirmed as a negative regulator controlling cyclic GMP-AMP synthase (cGAS)–dependent inflammation (142), providing a new clue to restrain colitis by regulating GSDMD (142). Here, CGAS is linked to colitis.